Sterol regulatory element-binding protein 1

SREBF1
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	1AM9
Identifiers
Aliases	SREBF1, SREBP-1c, SREBP1, bHLHd1, SREBP1a, sterol regulatory element binding transcription factor 1
External IDs	OMIM: 184756 MGI: 107606 HomoloGene: 3079 GeneCards: SREBF1
Gene location (Human)
Chr.	Chromosome 17 (human)[1]
End	17,837,011 bp[1]
Gene location (Mouse)
Chr.	Chromosome 11 (mouse)[2]
End	60,222,581 bp[2]
RNA expression pattern
	More reference expression data
Gene ontology
Molecular function	• DNA binding; • sequence-specific DNA binding; • protein dimerization activity; • GO:0001131, GO:0001151, GO:0001130, GO:0001204 DNA-binding transcription factor activity; • sterol response element binding; • chromatin binding; • GO:0000980 RNA polymerase II cis-regulatory region sequence-specific DNA binding; • transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding; • GO:0001948 protein binding; • protein kinase binding; • RNA polymerase II regulatory region sequence-specific DNA binding; • GO:0038050, GO:0004886, GO:0038051 nuclear receptor activity; • GO:0001200, GO:0001133, GO:0001201 DNA-binding transcription factor activity, RNA polymerase II-specific; • GO:0001077, GO:0001212, GO:0001213, GO:0001211, GO:0001205 DNA-binding transcription activator activity, RNA polymerase II-specific; • GO:0032403 macromolecular complex binding; • GO:0010577 enzyme activator activity;
Cellular component	• cytoplasm; • integral component of membrane; • cytosol; • Golgi apparatus; • nuclear envelope; • endoplasmic reticulum membrane; • membrane; • intracellular membrane-bounded organelle; • Golgi membrane; • nucleoplasm; • endoplasmic reticulum; • ER to Golgi transport vesicle membrane; • cytoplasmic vesicle; • cell nucleus; • macromolecular complex;
Biological process	• positive regulation of histone deacetylation; • insulin receptor signaling pathway; • positive regulation of triglyceride biosynthetic process; • steroid metabolic process; • negative regulation of insulin secretion; • response to fatty acid; • lipid biosynthetic process; • response to glucagon; • regulation of protein stability; • regulation of transcription, DNA-templated; • response to retinoic acid; • response to organic cyclic compound; • lung development; • lipid metabolism; • regulation of insulin secretion; • regulation of transcription from RNA polymerase II promoter; • cellular response to starvation; • response to progesterone; • aging; • response to peptide hormone; • mRNA transcription from RNA polymerase II promoter; • cholesterol metabolic process; • negative regulation of transcription from RNA polymerase II promoter; • response to glucose; • transcription, DNA-templated; • positive regulation of transcription, DNA-templated; • response to lipid; • cellular response to fatty acid; • regulation of autophagy of mitochondrion; • regulation of protein targeting to mitochondrion; • regulation of fatty acid metabolic process; • circadian rhythm; • cellular response to insulin stimulus; • response to food; • positive regulation of cholesterol biosynthetic process; • response to cAMP; • regulation of heart rate by chemical signal; • fat cell differentiation; • response to drug; • intracellular receptor signaling pathway; • positive regulation of transcription from RNA polymerase II promoter; • regulation of cholesterol biosynthetic process; • transcription from RNA polymerase II promoter; • positive regulation of pri-miRNA transcription from RNA polymerase II promoter; • GO:0048554 positive regulation of catalytic activity;
	Sources:Amigo / QuickGO
Orthologs
	6720
	20787
	ENSG00000072310
	ENSMUSG00000020538
	P36956
	Q9WTN3
	NM_001005291; NM_004176; NM_001321096
	NM_011480; NM_001313979; NM_001358314; NM_001358315
	NP_001005291; NP_001308025; NP_004167
	NP_001300908; NP_035610; NP_001345243; NP_001345244
	Wikidata
View/Edit Human	View/Edit Mouse

Sterol regulatory element-binding transcription factor 1 (SREBF1) also known as sterol regulatory element-binding protein 1 (SREBP-1) is a protein that in humans is encoded by the SREBF1 gene.[5][6]

This gene is located within the Smith–Magenis syndrome region on chromosome 17. Two transcript variants encoding different isoforms have been found for this gene.[7] The isoforms are SREBP-1a and SREBP-1c (the latter also called ADD-1). SREBP-1a is expressed in the intestine and spleen, whereas SREBP-1c is mainly expressed in liver, muscle, and fat (among other tissues).

Expression

The proteins encoded by this gene are transcription factors that bind to a sequence in the promoter of different genes, called sterol regulatory element-1 (SRE1). This element is a decamer (oligomer with ten subunits) flanking the LDL receptor gene and other genes involved in, for instance, sterol biosynthesis. The protein is synthesized as a precursor that is attached to the nuclear membrane and endoplasmic reticulum. Following cleavage, the mature protein translocates to the nucleus and activates transcription by binding to the SRE1. Sterols inhibit the cleavage of the precursor, and the mature nuclear form is rapidly catabolized, thereby reducing transcription. The protein is a member of the basic helix-loop-helix-leucine zipper (bHLH-Zip) transcription factor family.

SREBP-1a regulates genes related to lipid and cholesterol production and its activity is regulated by sterol levels in the cell.[8]

SREBP-1a and SREBP-1c are both encoded by the same gene, but are transcribed by different promoters.[9] For animals in a fasted state, SREBP-1c expression is suppressed in the liver, but a high carbohydrate meal (by insulin release) strongly induces SREBP-1c expression.[9]

Function

SREBP-1 plays a key role in the induction of lipogenesis by the liver.[10] mTORC1 is activated by insulin (a hormone of nutrient abundance) leading to increased production of SBREP-1c, which facilitates storage of fatty acids (excess nutrients) as triglycerides.[11]

Clinical relevance

SREBP-1c regulates genes required for glucose metabolism and fatty acid and lipid production and its expression is induced by insulin.[12] Insulin-stimulated SREBP-1c increases glycolysis by activation of glucokinase enzyme, and increases lipogenesis (conversion of carbohydrates into fatty acids).[12] Insulin stimulation of SREBP-1c is mediated by liver X receptor (LXR) and mTORC1.[13]

High blood levels of insulin due to insulin resistance often leads to steatosis in the liver because of SREBP-1 activation.[9] Suppression of SREBP-1c by sirtuin 1 [14] or by other means[15] protects against development of fatty liver.

SREBP-1 is highly activated in cancers because tumor cells require lipids for cell membranes, second messengers, and energy.[16]

Interactions

SREBF1 has been shown to interact with:

References

GRCh38: Ensembl release 89: ENSG00000072310 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000020538 - Ensembl, May 2017
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS (Oct 1993). "SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene". Cell. 75 (1): 187–97. doi:10.1016/S0092-8674(05)80095-9. PMID 8402897. S2CID 2784016.
Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH (Feb 1995). "Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13". Genomics. 25 (3): 667–73. doi:10.1016/0888-7543(95)80009-B. PMID 7759101.
"Entrez Gene: SREBF1 sterol regulatory element binding transcription factor 1".
Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F (Nov 2004). "SREBP transcription factors: master regulators of lipid homeostasis". Biochimie. 86 (11): 839–48. doi:10.1016/j.biochi.2004.09.018. PMID 15589694.
Xu X, So JS, Park JG, Lee AH (2013). "Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP". Seminars in Liver Disease. 33 (4): 301–311. doi:10.1055/s-0033-1358523. PMC 4035704. PMID 24222088.
Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S, Yamada N (1999). "Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme gene". Journal of Biological Chemistry. 274 (50): 35832–9. doi:10.21037/hbsn.2016.11.08. PMC 5218901. PMID 10585467.
Li S, Brown MS, Goldstein JL (2010). "Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis". Proceedings of the National Academy of Sciences of the United States of America. 107 (8): 3441–3446. Bibcode:2010PNAS..107.3441L. doi:10.1073/pnas.0914798107. PMC 2840492. PMID 20133650.
Ferré P, Foufelle F (Oct 2010). "Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c". Diabetes, Obesity & Metabolism. 12 Suppl 2 (Suppl 2): 83–92. doi:10.1111/j.1463-1326.2010.01275.x. PMID 21029304. S2CID 23614683.
Bakan I, Laplante M (2012). "Connecting mTORC1 signaling to SREBP-1 activation". Current Opinion in Lipidology. 23 (3): 226–234. doi:10.1097/MOL.0b013e328352dd03. PMID 22449814. S2CID 19390378.
Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, Zang M, Wu SY, Chiang CM, Veenstra TD, Kemper JK (2010). "SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism". Journal of Biological Chemistry. 285 (44): 33959–70. doi:10.1074/jbc.M110.122978. PMC 2962496. PMID 20817729.
Song Z, Xiaoli AM, Yang F (2018). "Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues". Nutrients. 10 (10): E1383. doi:10.3390/nu10101383. PMC 6213738. PMID 30274245.
Guo D, Bell EH, Mischel P, Chakravarti A (2014). "Targeting SREBP-1-driven lipid metabolism to treat cancer". Current Pharmaceutical Design. 20 (15): 2619–2626. doi:10.2174/13816128113199990486. PMC 4148912. PMID 23859617.
Oliner JD, Andresen JM, Hansen SK, Zhou S, Tjian R (Nov 1996). "SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein". Genes & Development. 10 (22): 2903–11. doi:10.1101/gad.10.22.2903. PMID 8918891.
Lopez D, Shea-Eaton W, Sanchez MD, McLean MP (Dec 2001). "DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein-1a and steroidogenic factor-1". Endocrinology. 142 (12): 5097–106. doi:10.1210/endo.142.12.8523. PMID 11713202.
Lloyd DJ, Trembath RC, Shackleton S (Apr 2002). "A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies". Human Molecular Genetics. 11 (7): 769–77. doi:10.1093/hmg/11.7.769. PMID 11929849.
Lee YS, Lee HH, Park J, Yoo EJ, Glackin CA, Choi YI, Jeon SH, Seong RH, Park SD, Kim JB (Dec 2003). "Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c". Nucleic Acids Research. 31 (24): 7165–74. doi:10.1093/nar/gkg934. PMC 291873. PMID 14654692.
Gorski, Jeffery; Price, Jeffery (2016). "Bone muscle crosstalk targets muscle regeneration pathway regulated by core circadian transcriptional repressors DEC1 and DEC2". BoneKEy Reports. 5: 850. doi:10.1038/bonekey.2016.80. PMC 5111231. PMID 27867498. Retrieved 2017-04-13.

External links

SREBF1+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)
FactorBook SREBP1

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000072310 - Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000020538 - Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[pmid8402897-5] Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS (Oct 1993). "SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene". Cell. 75 (1): 187–97. doi:10.1016/S0092-8674(05)80095-9. PMID 8402897. S2CID 2784016.

[pmid7759101-6] Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH (Feb 1995). "Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13". Genomics. 25 (3): 667–73. doi:10.1016/0888-7543(95)80009-B. PMID 7759101.

[7] "Entrez Gene: SREBF1 sterol regulatory element binding transcription factor 1".

[pmid15589694-8] Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F (Nov 2004). "SREBP transcription factors: master regulators of lipid homeostasis". Biochimie. 86 (11): 839–48. doi:10.1016/j.biochi.2004.09.018. PMID 15589694.

[pmid24222088-9] Xu X, So JS, Park JG, Lee AH (2013). "Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP". Seminars in Liver Disease. 33 (4): 301–311. doi:10.1055/s-0033-1358523. PMC 4035704. PMID 24222088.

[pmid10585467-10] Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S, Yamada N (1999). "Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme gene". Journal of Biological Chemistry. 274 (50): 35832–9. doi:10.21037/hbsn.2016.11.08. PMC 5218901. PMID 10585467.

[pmid20133650-11] Li S, Brown MS, Goldstein JL (2010). "Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis". Proceedings of the National Academy of Sciences of the United States of America. 107 (8): 3441–3446. Bibcode:2010PNAS..107.3441L. doi:10.1073/pnas.0914798107. PMC 2840492. PMID 20133650.

[pmid21029304-12] Ferré P, Foufelle F (Oct 2010). "Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c". Diabetes, Obesity & Metabolism. 12 Suppl 2 (Suppl 2): 83–92. doi:10.1111/j.1463-1326.2010.01275.x. PMID 21029304. S2CID 23614683.

[pmid22449814-13] Bakan I, Laplante M (2012). "Connecting mTORC1 signaling to SREBP-1 activation". Current Opinion in Lipidology. 23 (3): 226–234. doi:10.1097/MOL.0b013e328352dd03. PMID 22449814. S2CID 19390378.

[pmid20817729-14] Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, Zang M, Wu SY, Chiang CM, Veenstra TD, Kemper JK (2010). "SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism". Journal of Biological Chemistry. 285 (44): 33959–70. doi:10.1074/jbc.M110.122978. PMC 2962496. PMID 20817729.

[pmid30274245-15] Song Z, Xiaoli AM, Yang F (2018). "Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues". Nutrients. 10 (10): E1383. doi:10.3390/nu10101383. PMC 6213738. PMID 30274245.

[pmid23859617-16] Guo D, Bell EH, Mischel P, Chakravarti A (2014). "Targeting SREBP-1-driven lipid metabolism to treat cancer". Current Pharmaceutical Design. 20 (15): 2619–2626. doi:10.2174/13816128113199990486. PMC 4148912. PMID 23859617.

[pmid8918891-17] Oliner JD, Andresen JM, Hansen SK, Zhou S, Tjian R (Nov 1996). "SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein". Genes & Development. 10 (22): 2903–11. doi:10.1101/gad.10.22.2903. PMID 8918891.

[pmid11713202-18] Lopez D, Shea-Eaton W, Sanchez MD, McLean MP (Dec 2001). "DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein-1a and steroidogenic factor-1". Endocrinology. 142 (12): 5097–106. doi:10.1210/endo.142.12.8523. PMID 11713202.

[pmid11929849-19] Lloyd DJ, Trembath RC, Shackleton S (Apr 2002). "A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies". Human Molecular Genetics. 11 (7): 769–77. doi:10.1093/hmg/11.7.769. PMID 11929849.

[pmid14654692-20] Lee YS, Lee HH, Park J, Yoo EJ, Glackin CA, Choi YI, Jeon SH, Seong RH, Park SD, Kim JB (Dec 2003). "Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c". Nucleic Acids Research. 31 (24): 7165–74. doi:10.1093/nar/gkg934. PMC 291873. PMID 14654692.

[:0-21] Gorski, Jeffery; Price, Jeffery (2016). "Bone muscle crosstalk targets muscle regeneration pathway regulated by core circadian transcriptional repressors DEC1 and DEC2". BoneKEy Reports. 5: 850. doi:10.1038/bonekey.2016.80. PMC 5111231. PMID 27867498. Retrieved 2017-04-13.